Status:
UNKNOWN
Prenatal Screening for Congenital Heart Diseases in the Antwerp Region
Lead Sponsor:
Universiteit Antwerpen
Conditions:
Congenital Heart Disease in Pregnancy
Eligibility:
FEMALE
18-49 years
Brief Summary
No systematic research has been done in the last 15 years on the accuracy of prenatal ultrasound of congenital heart diseases in Belgium. Nor are there any population-based studies available on this s...
Detailed Description
Congenital heart defects are a leading cause of infant mortality with an incidence of 0,4-1,3% at birth. Although prenatal detection rates vary widely, morphological (structural) cardiac malformations...
Eligibility Criteria
Inclusion
- Inclusion criteria
- All fetal congenital heart diseases registered in the Antwerp-EUROCAT database,
- In the period 1/1/1997-31/12/2017 period
- Exclusion criteria
- All cases of congenital heart diseases where the mother was under \<18 years old.
- All cases of congenital heart diseases were the parents did not allow inclusion in the EUROCAT registered.
- All cases of congenital heart diseases where the mother delivered outside the EC countries.
Exclusion
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04382222
Start Date
June 1 2020
End Date
December 1 2021
Last Update
May 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Antwerp
Edegem, Antwerp, Belgium, 2650